litlas
Log inCreate account

Chi V. Dang

Active 1979–2025

167
Papers
69,192
Citations
115
h-index
165
i10-index

Citations

Citations per year for Chi V. Dang1961: 1 citations1968: 1 citations1982: 1 citations1983: 1 citations1984: 4 citations1985: 2 citations1986: 11 citations1987: 5 citations1988: 2 citations1989: 31 citations1990: 51 citations1991: 64 citations1992: 101 citations1993: 103 citations1994: 112 citations1995: 121 citations1996: 117 citations1997: 114 citations1998: 87 citations1999: 172 citations2000: 241 citations2001: 242 citations2002: 252 citations2003: 236 citations2004: 241 citations2005: 261 citations2006: 376 citations2007: 467 citations2008: 700 citations2009: 734 citations2010: 858 citations2011: 860 citations2012: 1,055 citations2013: 1,038 citations2014: 1,102 citations2015: 984 citations2016: 960 citations2017: 1,147 citations2018: 1,047 citations2019: 2,749 citations2020: 2,996 citations2021: 2,831 citations2022: 2,203 citations2023: 1,778 citations2024: 2,434 citations2025: 1,275 citations2026: 28 citations1962–1967: no citations, so these years are not shown1969–1981: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 9,115 citing papers, 30.6% of this breakdownChina: 5,563 citing papers, 18.7% of this breakdownUnited Kingdom: 1,502 citing papers, 5% of this breakdownGermany: 1,402 citing papers, 4.7% of this breakdownItaly: 1,094 citing papers, 3.7% of this breakdownJapan: 858 citing papers, 2.9% of this breakdownCanada: 840 citing papers, 2.8% of this breakdownFrance: 792 citing papers, 2.6% of this breakdownSpain: 622 citing papers, 2.1% of this breakdownIndia: 616 citing papers, 2.1% of this breakdownSouth Korea: 543 citing papers, 1.8% of this breakdownAustralia: 524 citing papers, 1.8% of this breakdown
0%30.6%Other 21.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology65.5%
  • Medicine22.6%
  • Immunology and Microbiology5.1%
  • Neuroscience2.1%
  • Engineering1.1%
  • Chemistry0.8%
  • Other2.8%

Topics

  • Cancer, Hypoxia, and Metabolism9.9%
  • RNA modifications and cancer3.5%
  • Epigenetics and DNA Methylation3%
  • MicroRNA in disease regulation2.8%
  • Cancer-related molecular mechanisms research2.8%
  • Mitochondrial Function and Pathology2.7%
  • Other75.3%

Coauthors

All papers

Open in search
  1. Targeting cancer metabolism in the era of precision oncology

    Authors: Zachary E. Stine, Zachary T. Schug, Joseph M. Salvino, Chi V. Dang - Nature Reviews Drug Discovery 2021 cited by 1,194

  2. Otto Warburg's contributions to current concepts of cancer metabolism

    Authors: Willem H. Koppenol, Patricia L. Bounds, Chi V. Dang - Nature reviews. Cancer 2011 cited by 3,432

  3. HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

    Authors: Jung‐whan Kim, Irina Tchernyshyov, Gregg L. Semenza, Chi V. Dang - Cell Metabolism 2006 cited by 3,876

  4. From Krebs to clinic: glutamine metabolism to cancer therapy

    Authors: Brian J. Altman, Zachary E. Stine, Chi V. Dang - Nature reviews. Cancer 2016 cited by 2,122

  5. MYC on the Path to Cancer

    Authors: Chi V. Dang - Cell 2012 cited by 3,451

  6. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

    Authors: Anne Le, Charles R. Cooper, Arvin M. Gouw, Ramani Dinavahi, Anirban Maitra, Lorraine M. Deck, Robert E. Royer, David L. Vander Jagt, Gregg L. Semenza, Chi V. Dang - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 1,504

  7. Drugging the 'undruggable' cancer targets

    Authors: Chi V. Dang, E. Premkumar Reddy, Kevan M. Shokat, Laura Soucek - Nature reviews. Cancer 2017 cited by 907

  8. Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1

    Authors: Eric V. Dang, Joseph Barbi, Huang‐Yu Yang, Dilini Jinasena, Hong Yu, Ying Zheng, Zachary Bordman, Juan Fu, Young Kim, Hung‐Rong Yen, Weibo Luo, Karen Zeller, Larissa A. Shimoda, Suzanne L. Topalian, Gregg L. Semenza, Chi V. Dang, Drew M. Pardoll, Fan Pan - Cell 2011 cited by 1,588

  9. The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer

    Authors: Gauri Mirji, Alison Worth, Sajad A. Bhat, Mohamed El Sayed, Toshitha Kannan, Aaron R. Goldman, Hsin‐Yao Tang, Qin Liu, Noam Auslander, Chi V. Dang, Mohamed Abdel‐Mohsen, Andrew V. Kossenkov, Ben Z. Stanger, Rahul Shinde - Science Immunology 2022 cited by 295

  10. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism

    Authors: Ping Gao, Irina Tchernyshyov, Tsung-Cheng Chang, Yun‐Sil Lee, Kayoko Kita, Takafumi Ochi, Karen Zeller, Angelo M. De Marzo, Jennifer E. Van Eyk, Joshua T. Mendell, Chi V. Dang - Nature 2009 cited by 2,131

  11. MYC, Metabolism, and Cancer

    Authors: Zachary E. Stine, Zandra E. Walton, Brian J. Altman, Annie L. Hsieh, Chi V. Dang - Cancer Discovery 2015 cited by 1,451

  12. HIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells

    Authors: Ryo Fukuda, Huafeng Zhang, Jung‐whan Kim, Larissa A. Shimoda, Chi V. Dang, Gregg L. Semenza - Cell 2007 cited by 1,224

  13. Glucose-Independent Glutamine Metabolism via TCA Cycling for Proliferation and Survival in B Cells

    Authors: Anne Le, Andrew N. Lane, Max Hamaker, Sminu Bose, Arvin M. Gouw, Joseph Barbi, Takashi Tsukamoto, Camilio J. Rojas, Barbara S. Slusher, Haixia Zhang, Lisa J. Zimmerman, D.C. Liebler, Robbert J.C. Slebos, Pawel Lorkiewicz, Richard M. Higashi, Teresa W.‐M. Fan, Chi V. Dang - Cell Metabolism 2012 cited by 1,092

  14. The c-Myc target gene network

    Authors: Chi V. Dang, Kathryn A. O’Donnell, Karen Zeller, Tam Nguyen, Rebecca C. Osthus, Feng Li - Seminars in Cancer Biology 2006 cited by 1,184

  15. Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc

    Authors: Rebecca C. Osthus, Hyunsuk Shim, Sunkyu Kim, Qing Li, Rahul Reddy, Mita Mukherjee, Yi Xu, Diane R. Wonsey, Linda A. Lee, Chi V. Dang - Journal of Biological Chemistry 2000 cited by 872

  16. Blocking Lactate Export by Inhibiting the Myc Target MCT1 Disables Glycolysis and Glutathione Synthesis

    Authors: Joanne R. Doherty, Chunying Yang, Kristen E.N. Scott, Michael D. Cameron, Mohammad Fallahi, Weimin Li, Mark A. Hall, Antonio L. Amelio, Jitendra K. Mishra, Fangzheng Li, Mariola Tortosa, Heide Marika Genau, Robert J. Rounbehler, Yunqi Lu, Chi V. Dang, K. Ganesh Kumar, Andrew A. Butler, Thomas D. Bannister, Andrea T. Hooper, Keziban Ünsal-Kaçmaz, William Roush, John L. Cleveland - Cancer Research 2013 cited by 397

  17. c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth

    Authors: Hyunsuk Shim, Christine Dolde, Brian C. Lewis, Chyi-Sun Wu, Gerard Dang, Richard A. Jungmann, Riccardo Dalla‐Favera, Chi V. Dang - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 1,105

  18. Targeting glutamine dependence through GLS1 inhibition suppresses ARID1A-inactivated clear cell ovarian carcinoma

    Authors: Shuai Wu, Takeshi Fukumoto, Jianhuang Lin, Timothy Nacarelli, Yemin Wang, Dionzie Ong, Heng Liu, Nail Fatkhutdinov, Joseph A. Zundell, Sergey Karakashev, Wei Zhou, Lauren E. Schwartz, Hsin‐Yao Tang, Ronny Drapkin, Qin Liu, David G. Huntsman, Andrew V. Kossenkov, David W. Speicher, Zachary T. Schug, Chi V. Dang, Rugang Zhang - Nature Cancer 2021 cited by 125

  19. MYC-Induced Cancer Cell Energy Metabolism and Therapeutic Opportunities

    Authors: Chi V. Dang, Anne Le, Ping Gao - Clinical Cancer Research 2009 cited by 978

  20. c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism

    Authors: Chi V. Dang - Molecular and Cellular Biology 1999 cited by 1,737

  21. Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1

    Authors: Jung‐whan Kim, Ping Gao, Yen-Chun Liu, Gregg L. Semenza, Chi V. Dang - Molecular and Cellular Biology 2007 cited by 641

  22. Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation

    Authors: Jianbin Wang, Jon W. Erickson, Reina N. Fuji, Sekar Ramachandran, Ping Gao, Ramani Dinavahi, Kristin F. Wilson, A.L.B. Ambrosio, Sandra Martha Gomes Dias, Chi V. Dang, Richard A. Cerione - Cancer Cell 2010 cited by 816

  23. HIF-1 Inhibits Mitochondrial Biogenesis and Cellular Respiration in VHL-Deficient Renal Cell Carcinoma by Repression of C-MYC Activity

    Authors: Huafeng Zhang, Ping Gao, Ryo Fukuda, Ganesh Kumar, Balaji Krishnamachary, Karen Zeller, Chi V. Dang, Gregg L. Semenza - Cancer Cell 2007 cited by 878

  24. Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis

    Authors: Yan Xiang, Zachary E. Stine, Jinsong Xia, Yunqi Lu, Roddy S. O’Connor, Brian J. Altman, Annie L. Hsieh, Arvin M. Gouw, Ajit G. Thomas, Ping Gao, Linchong Sun, Libing Song, Benedict Yan, Barbara S. Slusher, Jingli Zhuo, London Lucien Ooi, Caroline Lee, Anthony Mancuso, Andrew S. McCallion, Anne Le, Michael C. Milone, Stephen Rayport, Dean W. Felsher, Chi V. Dang - Journal of Clinical Investigation 2015 cited by 397